NCT07392879 Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients Status RECRUITING Phase NA
NCT07282574 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS) Status RECRUITING Phase PHASE2
NCT07139743 Obe-cel in Refractory Progressive Forms of Multiple Sclerosis Status RECRUITING Phase PHASE1
NCT07006805 RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06675864 Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS) Status RECRUITING Phase PHASE1/PHASE2
NCT06566261 ABA-101 in Participants With Progressive Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06451159 A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06261528 Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis Status ENROLLING_BY_INVITATION Phase PHASE1
NCT05811013 Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis Status RECRUITING Phase NA
NCT05740722 Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis Status RECRUITING Phase PHASE2
NCT05706220 Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis Status ENROLLING_BY_INVITATION Phase N/A
NCT05685784 Multiple Sclerosis Prediction and Monitoring of Progression Study Status RECRUITING Phase NA
NCT05441488 Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis Status SUSPENDED Phase PHASE3
NCT04749667 Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04695080 ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04289909 Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS) Status COMPLETED Phase NA